Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| PF-06250112 | C22H20F2N6O2 | 1609465-89-5 | Details |
| (Rac)-Plevitrexed；(Rac)-BGC9331;(Rac)-ZD 9331 | C26H25FN8O4 | 153538-08-0 | Details |
| (Rac)-Rotigotine hydrochloride | C19H26ClNOS | 102120-99-0 | Details |
| (Rac)-PT2399 | C17H10F5NO4S | 1672662-07-5 | Details |
| (Rac)-SEP-363856；(Rac)-SEP-856 | C9H13NOS | 1310426-29-9 | Details |
| PT2399 | C17H10F5NO4S | 1672662-14-4 | Details |
| RAD51-IN-2 | C27H40N4O6S2 | 2301085-04-9 | Details |
| (±)-Darifenacin；(±)-UK-88525 | C28H30N2O2 | 133033-93-9 | Details |
| Radafaxine hydrochloride；BW-306U;GW-353162A | C13H19Cl2NO2 | 106083-71-0 | Details |
| Dixanthogen；Scabicidol;Auligen;Aulinogen | C6H10O2S4 | 502-55-6 | Details |
| Radioprotectin-1 | C23H19ClN2O6S | 1622006-09-0 | Details |
| (Rac)-VU 6008667 | C24H17ClF2N2O2 | 2092917-63-8 | Details |
| (±)?-?Vasicine；(±)?-Peganine | C11H12N2O | 6159-56-4 | Details |
| (Rac)-Telmesteine；3,4-Thiazolidinedicarboxylic Acid 3-Ethyl Ester;3-(Ethoxycarbonyl)thiazolidine-4-carboxylic acid;3-ethoxycarbonyl-1,3-thiazolidine-4-carboxylic acid | C7H11NO4S | 127657-29-8 | Details |
| rel-α-Vitamin E；rel-D-α-Tocopherol;rel-(+)-α-Tocopherol | C29H50O2 | 2074-53-5 | Details |
| RAF mutant-IN-1 | C23H17Cl2FN6O2S | 2340020-82-6 | Details |
| RD3-0028 | C8H8S2 | 3886-39-3 | Details |
| Raloxifene 6,4'-Bis-β-D-glucuronide | C40H43NO16S | 182507-20-6 | Details |
| Ramelteon metabolite M-II | C16H21NO3 | 896736-21-3 | Details |
| Rasagiline 13C3 mesylate racemic；TVP1012 13C3 racemic;AGN1135 13C3 racemic | C13H17NO3S | 1216757-55-9 | Details |
| Refametinib (R enantiomer)；RDEA119 R enantiomer;BAY 869766 R enantiomer;Refametinib R enantiomer | C19H20F3IN2O5S | 923032-38-6 | Details |
| Rapamycin-d3；AY-22989-d3;Sirolimus-d3 | C51H76D3NO13 | 392711-19-2 | Details |
| Raloxifene 4'-glucuronide | C34H35NO10S | 182507-22-8 | Details |
| RBN-2397 | C20H23F6N7O3 | 2381037-82-5 | Details |
| Raloxifene 6-glucuronide | C34H35NO10S | 174264-50-7 | Details |
| Razaxaban hydrochloride；DPC 906 hydrochloride;BMS 561389 hydrochloride | C24H21ClF4N8O2 | 405940-76-3 | Details |
| RAS GTPase inhibitor 1 | C27H28ClF4N5O2 | 2252242-32-1 | Details |
| Tripelennamine hydrochloride；Tripelennamine HCl;Pyribenzamine hydrochloride;Pyribenzamine HCl | C16H22ClN3 | 154-69-8 | Details |
| Rapacuronium bromide；Org 9487 | C37H61BrN2O4 | 156137-99-4 | Details |
| Regorafenib-d3；BAY 73-4506 D3;Regorafenib D3 | C21H12ClD3F4N4O3 | 1255386-16-3 | Details |
| Rentiapril；SA-446 | C13H15NO4S2 | 80830-42-8 | Details |
| RG-12915 | C20H25ClN2O2 | 136174-04-4 | Details |
| Ritonavir metabolite；Desthiazolylmethyloxycarbonyl Ritonavir | C32H45N5O3S | 176655-55-3 | Details |
| Reutericyclin；Reutericycline | C20H31NO4 | 303957-69-9 | Details |
| Riviciclib；P276-00 (free base) | C21H20ClNO5 | 920113-02-6 | Details |
| Rislenemdaz；CERC-301;MK-0657 | C19H23FN4O2 | 808732-98-1 | Details |
| RG7834；RO 7020322 | C22H27NO6 | 2072057-17-9 | Details |
| Retro-2 cycl；RN 1-001 | C19H16N2OS | 1429192-00-6 | Details |
| Retagliptin Phosphate；SP 2086 | C19H18F6N4O3 | 1256756-88-3 | Details |
| RG7800；RO6885247 | C24H28N6O | 1449598-06-4 | Details |
| Resveratrol analog 1 | C14H11FO2 | 861446-16-4 | Details |
| (rel)-Tranylcypromine D5 hydrochloride；2-Phenylcyclopropylamine D5 hydrochloride | C9H7D5ClN | 107077-98-5 | Details |
| Rezafungin；SP-3025;CD101;Biafungin | C63H85N8O17 | 1396640-59-7 | Details |
| Reslizumab；Sch 55700 | 241473-69-8 | Details |
| Basimglurant；RG7090;CTEP Derivative | C18H13ClFN3 | 802906-73-6 | Details |
| Ribocil-C | C21H21N7OS | 1825355-56-3 | Details |
| Rezafungin acetate；SP-3025 acetate;CD101 acetate;Biafungin acetate | C65H88N8O19 | 1631754-41-0 | Details |
| ReN-1869 hydrochloride；NNC-05-1869 hydrochloride | C24H28ClNO2 | 170149-76-5 | Details |
| Resveratrol analog 2 | C16H13FO3 | 915378-82-4 | Details |
| Risperidone E-oxime | C23H28F2N4O2 | 691007-09-7 | Details |
| Reversan；CBLC4H10 | C26H27N5O2 | 313397-13-6 | Details |
| Cytarabine；Cytosine β-D-arabinofuranoside;Arabinocytidine;Ara-C;Cytosine Arabinoside | C9H13N3O5 | 147-94-4 | Details |
| Reverse transcriptase-IN-1 | C25H17N7O2 | 2380001-43-2 | Details |
| Resolvin D2；RvD2 | C22H32O5 | 810668-37-2 | Details |
| Reparixin L-lysine salt；Repertaxin L-lysine salt | C20H35N3O5S | 266359-93-7 | Details |
| Rho-Kinase-IN-1 | C20H24N4S | 1035094-83-7 | Details |
| Prinoxodan；RGW2938 | C13H14N4O2 | 111786-07-3 | Details |
| Rivaroxaban-d4；BAY 59-7939 D4;Rivaroxaban D4 | C19H18ClN3O5S | 1132681-38-9 | Details |
| REV7/REV3L-IN-1 | C19H21N3O3S | 1979192-13-6 | Details |
| RIG-1 modulator 1 | C14H17N5OS2 | 1428729-63-8 | Details |
| Vincristine sulfate；Leurocristine;22-Oxovincaleukoblastine sulfate;Leurocristine sulfate | C46H58N4O14S | 2068-78-2 | Details |
| (rel)-AR234960 | C27H30FN5O5S | 1408311-94-3 | Details |
| Rocuronium；Org-9426 | C32H53N2O4+ | 143558-00-3 | Details |
| Rosuvastatin D3 Sodium | C22H25D3FN3O6S | 1279031-70-7 | Details |
| Roflumilast Impurity E | C13H8Cl2F2N2O3 | 1391052-76-8 | Details |
| Ro 20-0657/000 | C14H18N4O4 | 29606-06-2 | Details |
| RIPK1-IN-4 | C23H23N5O2 | 1481641-08-0 | Details |
| Diacerein；Diacerhein;Fisiodar;Diacetylrhein | C19H12O8 | 13739-02-1 | Details |
| Ro 31-9790；GI4747 | C15H29N3O4 | 145337-55-9 | Details |
| RORγt Inverse agonist 8 | C26H33N7O2 | 2079892-79-6 | Details |
| RORγt Inverse agonist 6 | C28H29ClN6O5 | 1887161-80-9 | Details |
| Ro 25-6981 Maleate | C26H33NO6 | 1312991-76-6 | Details |
| ROR agonist-1 | C21H20F6N2O5S | 2361528-74-5 | Details |
| Retaspimycin | C31H45N3O8 | 857402-23-4 | Details |
| Retaspimycin Hydrochloride；IPI-504 | C31H47N3O8.ClH | 857402-63-2 | Details |
| RIP2 Kinase Inhibitor 3 | C19H24N4O3S | 1398053-50-3 | Details |
| ROCK inhibitor-2 | C21H20N2O2 | 1127308-52-4 | Details |
| Benzbromarone；Normurat;Urinorm;Desuric | C17H12Br2O3 | 3562-84-3 | Details |
| RIP1 kinase inhibitor 1 | C24H20ClN5O3 | 2095515-38-9 | Details |
| RORγt Inverse agonist 2 | C27H25F8NO5S | 1801197-92-1 | Details |
| Ro 41-3290 | C24H21ClN2O3 | 143943-72-0 | Details |
| Rivanicline；(E)-Metanicotine;RJR-2403 | C10H14N2 | 15585-43-0 | Details |
| RMI 10874 | C21H26N2O4 | 38020-45-0 | Details |
| Ro 25-6981 | C22H29NO2 | 169274-78-6 | Details |
| Phentolamine mesylate；Phentolamine methanesulfonate;Phentolamine mesilate | C18H23N3O4S | 65-28-1 | Details |
| RORγt agonist 1 | C24H17F6NO5S | 2377378-89-5 | Details |
| ROCK2-IN-2 | C18H12N6OS | 1995065-79-6 | Details |
| Rp-cAMPS triethylammonium salt | C16H27N6O5PS | 151837-09-1 | Details |
| Ro 10-5824 dihydrochloride | C17H21ClN4 | 189744-94-3 | Details |
| RIPK1-IN-3 | C22H19F3N6O3 | 2242677-36-5 | Details |
| ROS 234 dioxalate | C15H17N5O4 | 1781941-93-2 | Details |
| RO5256390 | C13H18N2O | 1043495-96-0 | Details |
| Ro-15-2041 | C12H12BrN3O | 77448-87-4 | Details |
| Danofloxacin mesylate；CP 76136-27 | C20H24FN3O6S | 119478-55-6 | Details |
| RORγt Inverse agonist 3 | C29H31Cl2N5O4S | 2364429-77-4 | Details |
| Rivanicline oxalate；RJR-2403 oxalate;(E)-Metanicotine oxalate | C12H16N2O4 | 220662-95-3 | Details |
| RO5263397 | C10H11FN2O | 1357266-05-7 | Details |
| RIPK1-IN-7 | C25H22F3N5O2 | 2300982-44-7 | Details |
| RO-7 | C24H20F3N3O3S | 1370241-45-4 | Details |
| RIP2 kinase inhibitor 1 | C17H17N5O2S | 2380028-10-2 | Details |
| Product Total： Product Page： | ||||
| 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 | ||||